SLRX — Salarius Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Salarius Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	11.1	29.2	12.1	5.9	2.43
Net Total Accounts Receivable
Net Total Receivables	3.86	0	1.61	0	—
Prepaid Expenses
Total Current Assets	15.8	30.2	14.5	6.52	2.99
Net Property, Plant And Equipment	0.023	0.008	—	—	—
Net Goodwill
Long Term Notes Receivable
Other Long Term Assets
Total Assets	24.9	40.8	14.7	6.59	3.02
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.77	2.11	4.27	1.3	1.51
Total Long Term Debt
Total Debt
Total Liabilities	2.77	2.11	4.27	1.3	1.51
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	22.2	38.7	10.4	5.29	1.51
Total Liabilities & Shareholders' Equity	24.9	40.8	14.7	6.59	3.02
Total Common Shares Outstanding